LSI USA '23 filling fast. Register Now

Durata Therapeutics

Long-acting, intravenous lipoglycopeptide used to treat acute bacterial skin and skin structure infections

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Durata Therapeutics plus 5456 other startups.

Start Free 7 Day Trial Now

Learn More About Durata Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Our Clients